NEW YORK, April 14 - Gyros of Uppsala, Sweden has licensed one of its patents for microfluidics devices to Cellectricon, a developer of a microchip for drug discovery, the companies said today.
Cellectricon has used processes that are covered by the Gyros patent to develop its Dynaflow Microchip, a device for drug discovery.
The patent, "Microfluidic structure and process for its manufacture," was granted in the USin December 1994 (Patent No. 5,376,252), and also has corresponding worldwide patents, according to Gyros. It covers microfluidic structures with two stable base layers and an elastic spacer in between.
This new agreement is one of many that Gyros is pursuing, said company executives. Gyros recently announced a similar licensing agreement with Fluidigm, of South San Francisco, Calif.